170 related articles for article (PubMed ID: 34307370)
1. Identification of Novel Serum Metabolic Biomarkers as Indicators in the Progression of Intravenous Leiomyomatosis: A High Performance Liquid Chromatography-Tandem Mass Spectrometry-Based Study.
Ge Z; Feng P; Zhang Z; Li J; Yu Q
Front Cell Dev Biol; 2021; 9():695540. PubMed ID: 34307370
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel serum protein biomarkers in the context of 3P medicine for intravenous leiomyomatosis: a data-independent acquisition mass spectrometry-based proteomics study.
Ge Z; Feng P; Zhang Z; Liang Z; Chen R; Li J
EPMA J; 2023 Dec; 14(4):613-629. PubMed ID: 38094583
[TBL] [Abstract][Full Text] [Related]
3. The identification of novel stroke-related sphingolipid biomarkers using UPLC-MS/MS.
Yang Z; Deng X; Zhu J; Chen S; Jiao C; Ruan Y
Clin Chim Acta; 2024 Jan; 552():117652. PubMed ID: 37979606
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics and Cytokine Analysis for Identification of Severe Drug-Induced Liver Injury.
Xie Z; Chen E; Ouyang X; Xu X; Ma S; Ji F; Wu D; Zhang S; Zhao Y; Li L
J Proteome Res; 2019 Jun; 18(6):2514-2524. PubMed ID: 31002254
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
6. [High-performance liquid chromatography-mass spectrometry-based serum metabolic profiling in patients with HBV-related hepatocellular carcinoma].
Zhang L; Fan Z; Kang H; Wang Y; Liu S; Shan Z
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):49-56. PubMed ID: 30692066
[TBL] [Abstract][Full Text] [Related]
7. Nonylphenol Toxicity Evaluation and Discovery of Biomarkers in Rat Urine by a Metabolomics Strategy through HPLC-QTOF-MS.
Zhang YX; Yang X; Zou P; Du PF; Wang J; Jin F; Jin MJ; She YX
Int J Environ Res Public Health; 2016 May; 13(5):. PubMed ID: 27187439
[TBL] [Abstract][Full Text] [Related]
8. LC-MS/MS and SWATH based serum metabolomics enables biomarker discovery in pancreatic cancer.
Xiong Y; Shi C; Zhong F; Liu X; Yang P
Clin Chim Acta; 2020 Jul; 506():214-221. PubMed ID: 32243985
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of Serum Metabonomics in Patients with Multiple Myeloma Based on Liquid Chromatography-Mass Spectrometry].
Xu XM; Kong XT; Yu H; Chen XL; Jiang PJ; Ni HW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):520-524. PubMed ID: 33812424
[TBL] [Abstract][Full Text] [Related]
10. [Rat plasma metabolomics in blood stasis model based on ultra performance liquid chromatography-quadrupole-time-of-flight mass spectrometry].
Yang X; Yang Z; Li S; Deng Y; Yang Y; Man Q; Li P
Se Pu; 2019 Jan; 37(1):71-79. PubMed ID: 30693712
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic experience of intravenous leiomyomatosis with emphasis on conventional ultrasonography imaging: a single-center study.
Ge Z; Wang Y; Wang Y; Li W; Yang X; Li J; Wang H
Front Oncol; 2023; 13():1203591. PubMed ID: 37492474
[TBL] [Abstract][Full Text] [Related]
12. Targeted High Performance Liquid Chromatography Tandem Mass Spectrometry-based Metabolomics differentiates metabolic syndrome from obesity.
Zhong F; Xu M; Bruno RS; Ballard KD; Zhu J
Exp Biol Med (Maywood); 2017 Apr; 242(7):773-780. PubMed ID: 28299975
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel serum metabolic signatures to predict chronic kidney disease among Chinese elders using UPLC-Orbitrap-MS.
Liu Y; Sun M; Sun J; Lin F; Xu D; Chen Y; Song W; Li Q; Jiang Y; Gu J; Li S; Gu L; Zhu X; Fang J; Chen M; Chen W
J Nutr Health Aging; 2024 Mar; 28(3):100036. PubMed ID: 38320382
[TBL] [Abstract][Full Text] [Related]
14. [Expression characteristics and diagnostic value of angiogenic molecules in intravenous leiomyomatosis].
Sun LJ; Zhou F; Benjoed BENJOED; Zhu CK; Lyu WG; Li Y
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(26):2005-2010. PubMed ID: 35817725
[No Abstract] [Full Text] [Related]
15. Serum metabolic profiling analysis of gout patients based on UPLC-Q-TOF/MS.
Zhong Z; Huang Y; Huang Q; Zheng S; Huang Z; Deng W; Li T
Clin Chim Acta; 2021 Apr; 515():52-60. PubMed ID: 33388309
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of urine metabolic profile in patients with hepatocellular carcinoma].
Chen X; Zhang L; Wu YJ; Liu SY; Liu HP
Zhonghua Gan Zang Bing Za Zhi; 2021 Aug; 29(8):788-793. PubMed ID: 34517462
[No Abstract] [Full Text] [Related]
17. MED12 exon 2 mutation is uncommon in intravenous leiomyomatosis: clinicopathologic features and molecular study.
Wang L; Hu S; Xin F; Zhao H; Li G; Ran W; Xing X; Wang J
Hum Pathol; 2020 May; 99():36-42. PubMed ID: 32240666
[TBL] [Abstract][Full Text] [Related]
18. UPLC-Q-TOF/MS-Based Plasma and Urine Metabolomics Contribute to the Diagnosis of Sepsis.
Guan S; Liu K; Liu Z; Zhou L; Jia B; Wang Z; Nie Y; Zhang X
J Proteome Res; 2022 Jan; 21(1):209-219. PubMed ID: 34941272
[TBL] [Abstract][Full Text] [Related]
19. Human Melanoma-Cell Metabolic Profiling: Identification of Novel Biomarkers Indicating Metastasis.
Kosmopoulou M; Giannopoulou AF; Iliou A; Benaki D; Panagiotakis A; Velentzas AD; Konstantakou EG; Papassideri IS; Mikros E; Stravopodis DJ; Gikas E
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244549
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
